Agent containing ergolin for transdermal application

Details for Australian Patent Application No. 2004271679 (hide)

Owner NeuroBiotec GmbH

Inventors Schenk, Dirk; Horowski, Reinhard; Bostedt, Katalin Tisa; Tack, Johannes

Agent Cullen & Co

Pub. Number AU-B-2004271679

PCT Pub. Number WO2005/025546

Priority 103 41 317.0 03.09.03 DE

Filing date 30 May 2004

Wipo publication date 24 March 2005

Acceptance publication date 20 September 2007

International Classifications

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/48 (2006.01) - Ergoline derivatives, e.g. lysergic acid, ergotamine

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/025546 Priority application(s): WO2005/025546

20 September 2007 Application Accepted

  Published as AU-B-2004271679

17 January 2008 Standard Patent Sealed

28 February 2008 Alteration of Name

  The name of the patentee has been altered to Axxonis Pharma AG

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004271685-A clamp for correcting the external ear and method of using the clamp

2004271668-Methods of stimulating innate immunity using cationic peptides